First Wave BioPharma, Inc. (FWBI) Financials

FWBI Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 5.9 million 2.6 million
June 30, 2023 4.3 million 3.4 million
March 31, 2023 5.5 million 2.8 million
Dec. 31, 2022 5.4 million 2.7 million

FWBI Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -3.3 million 263330
June 30, 2023 -2.8 million 292704
March 31, 2023 -2.8 million 358316
Dec. 31, 2022 -5.6 million 84346

FWBI Net Income

No data available :(

FWBI Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 3.3 million - 231292
June 30, 2023 1.2 million - 248226
March 31, 2023 2.1 million - 264460
Dec. 31, 2022 1.4 million - 280211

FWBI Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 7.6 million
June 30, 2023 2.3 million
March 31, 2023 325811
Dec. 31, 2022 995003

FWBI Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 1.0 million 2.4 million -
June 30, 2023 - 1.4 million 2.8 million -
March 31, 2023 - 1.4 million 2.7 million -
Dec. 31, 2022 - 101822 2.2 million -

FWBI Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 23413
June 30, 2023 - 23125
March 31, 2023 - 22846
Dec. 31, 2022 - 22573

FWBI

Price: $2.96

52 week price:
2.33
60.00

Earnings Per Share: -47.88 USD

P/E Ratio: 0.00

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 308700

Market Capitalization: 5.8 million

Links: